Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper P Kepp

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Monash Bioethics Review|September 3, 2024
Zero-covid advocacy during the COVID-19 pandemic: a case study of views on Twitter/XKasper P Kepp, Kevin Bardosh, Tijl De Bie, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 18, 2017
The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu<sup>2+</sup> -Aβ ComplexArun K Somavarapu, Fei Shen, Kaare Teilum, et al.
Journal of Alzheimer'S Disease : JAD|June 19, 2023
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary NotesKasper P Kepp, Stefano L Sensi, Kasper B Johnsen, et al.
Ageing Research Reviews|June 3, 2024
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefitPoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.
Ageing Research Reviews|December 17, 2023
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin villagePoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.
Frontiers in Public Health|August 11, 2023
Policies on children and schools during the SARS-CoV-2 pandemic in Western EuropeAntoni Soriano-Arandes, Ana Brett, Danilo Buonsenso, et al.
Current Medical Research and Opinion|January 24, 2025
Communicating scientific evidence: drugs for Alzheimer's disease as a case studyKasper P Kepp, Poul F Høilund-Carlsen, Ioana A Cristea, et al.
Journal of Clinical Epidemiology|June 19, 2024
Panel stacking is a threat to consensus statement validityKasper P Kepp, Preben Aavitsland, Marcel Ballin, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Monash Bioethics Review|September 3, 2024
Zero-covid advocacy during the COVID-19 pandemic: a case study of views on Twitter/XKasper P Kepp, Kevin Bardosh, Tijl De Bie, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 18, 2017
The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu<sup>2+</sup> -Aβ ComplexArun K Somavarapu, Fei Shen, Kaare Teilum, et al.
Journal of Alzheimer'S Disease : JAD|June 19, 2023
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary NotesKasper P Kepp, Stefano L Sensi, Kasper B Johnsen, et al.
Ageing Research Reviews|June 3, 2024
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefitPoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.
Ageing Research Reviews|December 17, 2023
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin villagePoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.
Frontiers in Public Health|August 11, 2023
Policies on children and schools during the SARS-CoV-2 pandemic in Western EuropeAntoni Soriano-Arandes, Ana Brett, Danilo Buonsenso, et al.
Current Medical Research and Opinion|January 24, 2025
Communicating scientific evidence: drugs for Alzheimer's disease as a case studyKasper P Kepp, Poul F Høilund-Carlsen, Ioana A Cristea, et al.
Journal of Clinical Epidemiology|June 19, 2024
Panel stacking is a threat to consensus statement validityKasper P Kepp, Preben Aavitsland, Marcel Ballin, et al.
Pageof 11